Evidence map›Paper›PMID 39918445›Full record

Trial reportAIDS (London, England)2025

Bone mineral density changes in breastfeeding women with HIV on antiretroviral therapy in Eastern and Southern Africa.

Flavia Matovu Kiweewa, Lynda Stranix-Chibanda, Nonhlanhla Yende-Zuma, Sufia Dadabhai, Maxensia Owor, Sherika Hanley, Mandisa Nyati, Lameck Chinula, John M Pettifor, Sean S Brummel and 5 more

Abstract readObservational StudyRandomized Controlled Trial
In one paragraph

Trial report in AIDS (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Sex-specific bone architectural deficits among older adults living with HIV: a cross-sectional study from Zimbabwe.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2026
    Article
  2. Frontiers in endocrinology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Flavia Matovu KiweewaMakerere University-Johns Hopkins University (MU-JHU) Research Collaboration.
Lynda Stranix-ChibandaUniversity of Zimbabwe Faculty of Medicine and Health Sciences.
Nonhlanhla Yende-ZumaCentre for AIDS Programme of Research in South Africa.
Sufia DadabhaiJohns Hopkins Bloomberg of Public Health, Baltimore, Maryland, USA.
Maxensia OworMakerere University-Johns Hopkins University (MU-JHU) Research Collaboration.
Sherika HanleyCentre for AIDS Programme of Research in South Africa.
Mandisa NyatiUniversity of the Witwatersrand Faculty of Health Sciences, Johannesburg, South Africa.
Lameck ChinulaUniversity of North Carolina Project Malawi, Lilongwe, Malawi.
John M PettiforUniversity of the Witwatersrand Faculty of Health Sciences, Johannesburg, South Africa.
Sean S BrummelHarvard T.H. Chan School of Public Health, Boston, Massachusetts.
Jim AizireJohns Hopkins School of Medicine, Baltimore, Maryland, USA.
Taha E TahaUniversity of the Witwatersrand Faculty of Health Sciences, Johannesburg, South Africa.
Todd T BrownJohns Hopkins School of Medicine, Baltimore, Maryland, USA.
Mary Glenn FowlerJohns Hopkins School of Medicine, Baltimore, Maryland, USA.
Maternal Bone Health Study team

Funding

LOC-IMPAACT Leadership GroupPharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant Women in the USUM1AI068632 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI Jennifer Jao, Sharon A Nachman · 2011 to 2026
$278.1M
Statistical and Data Management Center-Pediatric,Adolescent, and Maternal CTGUM1AI068616 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Sean Scott Brummel, Marlene Ann Cooper · 2011 to 2026
$155.6M
UZ-UCSF CTUUM1AI069436 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ZVAVAHERA MIKE CHIRENJE, LYNDA STRANIX-CHIBANDA · 2012 to 2026
$75.9M
University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit 2024 SupplementUM1AI069423 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph J Eron, MINA CHRISTINE HOSSEINIPOUR · 2012 to 2026
$71.8M
LC - IMPAACT Leadership GroupUM1AI106716 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Grace M Aldrovandi · 2014 to 2026
$47.2M
The Malawi Clinical Trials UnitUM1AI069518 · NIAID · JOHNS HOPKINS UNIVERSITY · PI JACKY M JENNINGS, TAHA E TAHA · 2012 to 2026
$43.8M
Soweto Clinical Trials UnitUM1AI069453 · NIAID · WITS HEALTH CONSORTIUM (PTY), LTD · PI Glenda E Gray, Lerato Mohapi · 2012 to 2026
$40.9M
University of KwaZulu-Natal - CAPRISA HIV/AIDS Clinical Trials UnitUM1AI069469 · NIAID · UNIVERSITY OF KWAZULU-NATAL · PI QUARRAISHA ABDOOL KARIM · 2012 to 2026
$36.4M
The Johns Hopkins University - Uganda Clinical Trials UnitUM1AI069530 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MARY Glenn Fowler, Philippa Musoke · 2012 to 2026
$34.8M
Determining Bone Loss and Bone Mineral Density Recovery Following Repeat Pregnancy/Lactation Among HIV Women on ARTR01HD095825 · NICHD · JOHNS HOPKINS UNIVERSITY · PI FOWLER, MARY GLENN · 2018 to 2023
$2.8M
Mentoring in Endocrine and Metabolic Abnormalities in HIV and AgingK24AI120834 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BROWN, TODD T · 2015 to 2025
$1.8M
NIAID NIH HHS K24 AI120834NIAID NIH HHS UM1 AI068616NIAID NIH HHS UM1 AI068632NIAID NIH HHS UM1 AI069423NIAID NIH HHS UM1 AI069436NIAID NIH HHS UM1 AI069453NIAID NIH HHS UM1 AI069469NIAID NIH HHS UM1 AI069518NIAID NIH HHS UM1 AI069530NIAID NIH HHS UM1 AI106716NICHD NIH HHS HHSN275201800001CNICHD NIH HHS HHSN275201800001INICHD NIH HHS R01 HD095825
6 · The paper itself

Abstract

objectiveThe aim of this study was to describe postpartum bone mineral density (BMD) change among breastfeeding African women with HIV (WHIV) on life-long antiretroviral therapy (ART).

designIn IMPAACT P1084 s, postpartum BMD declines were greater in WHIV randomized to ART to prevent breastmilk transmission compared to infant nevirapine prophylaxis. This analysis extends the observation period through entry to a follow-on observational study, PROMOTE.

methodsLumbar spine, total hip, and femoral neck BMD were assessed using dual energy x-ray absorptiometry (DXA) at postpartum weeks 1 and 74 in P1084 s, and at PROMOTE entry. Participants were included if DXA data were available from PROMOTE entry and more than one earlier timepoint. Country-specific Z-scores were created by internal standardization to week 1 values. Linear mixed models, adjusted for country, estimated the average 5-year change in BMD z -scores between postpartum week 1 and PROMOTE entry. Linear regression assessed the association between maternal characteristics and the rate of change in BMD z -score.

resultsWe included BMD data from 519 participants between postpartum week 1 through PROMOTE entry [median (IQR) 4.6 (3.5-5.1) years postpartum]. For every 5 years passed, lumbar spine BMD Z -scores increased by + 0.250 units, while total hip and femoral neck BMD z -scores decreased by -0.173 and -0.141 units, respectively. Lumbar spine, total hip, and femoral neck BMD increased between postpartum week 74 and PROMOTE entry, but only lumbar spine BMD fully recovered to week 1 values.

conclusionGiven dampened total hip and femoral neck BMD recovery postbreastfeeding, longer term monitoring is needed to assess peri-/postmenopausal fracture risk, and interventions to optimize bone health among WLHIV on life-long ART.

Indexed as

Anti-Retroviral AgentsBone DensityBreast FeedingHIV InfectionsAbsorptiometry, PhotonAdultAfrica, EasternAfrica, SouthernFemaleHumansPostpartum PeriodYoung AdultAnti-Retroviral AgentsAfricaantiretroviral therapybone healthbreastfeeding womenHIVtenofovir

Identifiers

PMID39918445
PMCPMC12455725

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.